On July 29, THE CIGNA GROUP rose 3.26% in regular trading, trading at $300.59/share, with turnover of $185 million.

On the news front, the company is scheduled to release its Q2 earnings on July 30 pre-market. Market consensus expects quarterly revenue of approximately $71.25 billion, up 7.35% year-over-year, with adjusted EPS of approximately $8.27, representing an 8.69% year-over-year increase. Multiple institutions maintain bullish stances — Bernstein raised its price target to $381 while UBS maintains a Buy rating with a $400 target, reflecting strong confidence in the company's profit outlook.

Additionally, Cigna Healthcare recently announced an expansion of AI-backed care management capabilities, expected to identify 20% more clients with complex or chronic health needs for earlier clinical support, projecting $200 million in medical cost savings over three years. Morgan Stanley has also highlighted managed-care companies including Cigna as potential beneficiaries of AI-driven efficiency gains across the healthcare system.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)